Profile data is unavailable for this security.
About the company
IDT Australia Limited is a pharmaceutical manufacturing company. The Company is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities can produce both API and FDF positioning it as a facility in the medicinal cannabis manufacturing space. It also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.
- Revenue in AUD (TTM)10.36m
- Net income in AUD-6.55m
- Incorporated1986
- Employees156.00
- LocationIDT Australia Ltd45 Wadhurst Dr, BoroniaMELBOURNE 3155AustraliaAUS
- Phone+61 (39) 801-8888
- Fax+61 (39) 801-8773
- Websitehttps://en.idtaus.com.au/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LTR Pharma Ltd | -100.00bn | -100.00bn | 19.71m | -- | -- | 6.21 | -- | -- | -- | -- | -- | 0.0451 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -41.65 | -- | -- | -- |
| Immuron Ltd | 3.58m | -3.88m | 20.29m | 6.00 | -- | 1.16 | -- | 5.67 | -0.017 | -0.017 | 0.0157 | 0.0769 | 0.1664 | 0.6468 | 7.92 | 596,106.70 | -18.06 | -27.48 | -19.86 | -29.58 | 80.87 | 77.52 | -108.52 | -296.64 | 7.79 | -2.85 | 0.0023 | -- | 135.85 | -13.34 | -32.66 | -- | 3.27 | -- |
| Syntara Ltd | 9.83m | -14.26m | 21.49m | 107.00 | -- | 2.39 | -- | 2.19 | -0.0197 | -0.0172 | 0.0136 | 0.0075 | 0.442 | 1.58 | 2.22 | -- | -64.13 | -27.33 | -97.76 | -34.23 | 81.69 | 88.37 | -145.11 | -61.99 | 1.75 | -262.59 | 0.0674 | -- | 23.60 | -18.30 | -486.78 | -- | -31.06 | -- |
| Chimeric Therapeutics Ltd | 0.00 | -11.31m | 23.12m | -- | -- | 1.41 | -- | -- | -0.027 | -0.027 | 0.00 | 0.0191 | 0.00 | -- | -- | -- | -45.96 | -- | -69.36 | -- | -- | -- | -- | -- | -- | -10.01 | 0.1596 | -- | -- | -- | -60.40 | -- | -- | -- |
| BCAL Diagnostics Ltd | 3.67m | -5.00m | 23.72m | -- | -- | 3.90 | -- | 6.45 | -0.0227 | -0.0227 | 0.0166 | 0.0241 | 0.4493 | -- | 3.21 | -- | -61.10 | -54.01 | -67.83 | -62.57 | -- | -- | -136.00 | -248.64 | -- | -131.83 | 0.1985 | -- | 298.63 | 63.18 | -49.51 | -- | 91.62 | -- |
| Lumos Diagnostics Holdings Ltd | 12.41m | -13.33m | 24.07m | -- | -- | 1.73 | -- | 1.94 | -0.0358 | -0.0358 | 0.0352 | 0.029 | 0.3418 | 2.24 | 6.37 | -- | -36.70 | -40.15 | -55.14 | -56.67 | 59.73 | 45.97 | -107.38 | -162.90 | 0.479 | -6.25 | 0.4803 | -- | -9.42 | 39.29 | 80.38 | -- | -38.50 | -- |
| LBT Innovations Limited | 2.00m | -21.38m | 24.11m | 17.00 | -- | 8.88 | -- | 12.03 | -0.0428 | -0.0428 | 0.0038 | 0.002 | 0.1087 | 0.0819 | 2.25 | 117,882.40 | -115.89 | -28.85 | -131.86 | -30.99 | 94.76 | -- | -1,066.62 | -441.76 | 3.30 | -6.85 | 0.5633 | -- | -5.29 | -18.45 | -239.17 | -- | -34.63 | -- |
| Alterity Therapeutics Ltd | 123.46k | -12.28m | 26.23m | 11.00 | -- | 0.7951 | -- | 212.42 | -0.005 | -0.005 | 0.00005 | 0.0063 | 0.0044 | -- | 1.52 | 11,223.64 | -44.20 | -53.02 | -53.57 | -61.96 | -- | -- | -9,947.97 | -40,995.62 | -- | -- | 0.0143 | -- | 557.60 | -39.40 | -7.47 | -- | -34.88 | -- |
| BPH Energy Ltd | 345.67k | 894.65k | 26.34m | 2.00k | 24.49 | 1.18 | -- | 76.20 | 0.001 | 0.001 | 0.0004 | 0.0203 | 0.0177 | -- | 5.97 | -- | 4.58 | -6.89 | 4.78 | -7.72 | 56.39 | -- | 258.50 | -357.76 | -- | -- | 0.0043 | -- | 96.54 | 5.21 | 179.13 | -- | -- | -- |
| Cann Group Ltd | 16.45m | -29.28m | 27.12m | 40.00 | -- | 0.5339 | -- | 1.65 | -0.0724 | -0.0724 | 0.0406 | 0.1161 | 0.1237 | 0.3952 | 7.37 | -- | -22.03 | -22.28 | -34.23 | -24.43 | 21.11 | -- | -178.07 | -407.57 | 0.0861 | -5.88 | 0.5646 | -- | 114.90 | 89.76 | -27.66 | -- | -11.16 | -- |
| Invion Ltd | 4.46m | -1.50m | 32.12m | 8.00 | -- | 1.80 | -- | 7.20 | -0.0002 | -0.0002 | 0.0007 | 0.0028 | 0.2345 | -- | 3.20 | -- | -7.88 | -16.93 | -8.12 | -18.13 | -- | -- | -33.60 | -51.63 | -- | -- | 0.00 | -- | 25.72 | 41.18 | 27.95 | -- | -- | -- |
| Prescient Therapeutics Ltd | 697.94k | -7.74m | 33.02m | 3.00 | -- | 1.46 | -- | 47.31 | -0.0098 | -0.0098 | 0.0009 | 0.0281 | 0.0276 | -- | 2.32 | -- | -30.58 | -27.61 | -32.59 | -29.03 | -- | -- | -1,109.58 | -3,284.78 | -- | -412.91 | 0.00 | -- | 939.16 | 29.68 | -36.88 | -- | -- | -- |
| IDT Australia Limited | 10.36m | -6.55m | 33.39m | 156.00 | -- | 1.45 | -- | 3.22 | -0.022 | -0.022 | 0.035 | 0.0656 | 0.3741 | 2.39 | 3.51 | -- | -23.64 | -9.87 | -26.41 | -11.57 | 76.38 | 84.42 | -63.19 | -24.94 | 2.81 | -- | 0.0907 | -- | -42.03 | -11.97 | -632.59 | -- | -26.04 | -- |
| Little Green Pharma Ltd | 23.24m | -3.14m | 39.23m | -- | -- | 0.4835 | 58.71 | 1.69 | -0.011 | -0.0126 | 0.0833 | 0.2689 | 0.263 | 1.13 | 12.06 | -- | -3.55 | -- | -4.01 | -- | 51.02 | -- | -13.51 | -- | 2.03 | -21.27 | 0.0667 | -- | -- | -- | -- | -- | -- | -- |
| Cynata Therapeutics Ltd | 436.25k | -13.65m | 40.42m | 0.00 | -- | 3.29 | -- | 92.65 | -0.0873 | -0.0873 | 0.0027 | 0.0683 | 0.0257 | -- | 4.26 | -- | -80.33 | -38.07 | -87.15 | -41.10 | -- | -- | -3,127.93 | -513.73 | -- | -- | 0.00 | -- | -94.96 | 19.81 | -162.20 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to IDT Australia Ltd's reporting currency: Australian Dollar AUD
26.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sandon Capital Pty Ltd.as of 09 Jun 2023 | 50.42m | 14.35% |
| Regal Funds Management Pty Ltd.as of 13 Jun 2023 | 43.58m | 12.40% |
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
